SHAREHOLDER ALERT: WeissLaw LLP Investigates CAS Medical Systems, Inc.

February 15, 2019 |

2 min read

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of CAS Medical Systems, Inc. in connection with the proposed acquisition of the Company by Edwards Lifesciences Corporation.

NEW YORK, Feb. 15, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of CAS Medical Systems, Inc. (“CASM” or the “Company”) (NASDAQ: CASM) in connection with the proposed acquisition of the Company by Edwards Lifesciences Corporation (“EW”). Under the terms of the acquisition agreement, shareholders will receive $2.45 in cash for each CASM share they own.

WeissLaw LLP Investigates CAS Medical Systems, Inc.

If you own CASM shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16^th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Visit our website
http://www.weisslawllp.com/cas-medical-inc/

Or follow us on Twitter @MarketsAlert

WeissLaw is investigating whether CASM’s Board acted to maximize shareholder value prior to entering into the agreement. Notably, the acquisition of CASM is a strategic transaction which EW hopes will propel it as an industry leader. According to EW’s Corporate Vice President, “the incorporation of [CASM]'s FORE-SIGHT technology . . . will strengthen [EW]'s leadership in smart monitoring technologies.”

Given these facts, WeissLaw is concentrating its investigation on whether CASM’s Board conducted a fair process in agreeing to the proposed acquisition, whether the proposed acquisition undervalues the Company, and whether all material information related to the proposed acquisition is fully and fairly disclosed.

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)